The third IGTP Scientific Retreat proves a success
The IGTP Retreat consolidates as a nexus of the research carried out at the Can Ruti Campus. This year the event has focused on ageing and a patient-centred model of care.
At the IGTP TODAY
The IGTP Retreat consolidates as a nexus of the research carried out at the Can Ruti Campus. This year the event has focused on ageing and a patient-centred model of care.
A research team, led by Dr. Conxi Lázaro, from IDIBELL and ICO, and Dr. Eduard Serra, from IGTP, has published in the journal Molecular Oncology the expansion of a precision medicine platform to analyse and improve treatments for malignant peripheral nerve sheath tumours.
A collaborative document outlining new guidelines for the isolation and characterisation of extracellular vesicles in parasitic disease research has been published in the Journal of Extracellular Biology. A research group from IGTP and ISGlobal contributed to the study, which could enhance our understanding of host-parasite interactions and advance early diagnosis, treatment, and prevention of parasite-caused diseases.
Researchers from IGTP have discovered that administering human apotransferrin to mice models affected by intracerebral haemorrhage can mitigate the damaging effects of this severe type of stroke. This finding highlights the promising role of apotransferrin as a pre-hospital and pre-triage frontline treatment for all stroke patients. The study has been published in the journal Antioxidants.
The Can Ruti Campus and the healthcare and research teams of the different institutions that comprise it continue to prove, once again this year, to be a relevant node on a global scale in terms of scientific production and progress.
Researchers from the IGTP have led a comprehensive review study on biomarkers for the often-overlooked partial remission phase of type 1 diabetes, in collaboration with experts in β-cell biology and regeneration from the Diabetes Research Institute in Miami. The study has been published in the journal Trends in Endocrinology and Metabolism.
The funds raised in the 2022 edition of La Marató de 3Cat will enable 71 research teams to conduct 37 projects in cardiovascular health to advance in the prevention, diagnosis, and treatment of diseases that represent the leading cause of death in developed countries. One of the awarded projects involves the participation of researchers from the GCAT of the IGTP, and is coordinated by Dr Camille Lassale from ISGlobal.
A collaborative study led by researchers from IGTP has revealed the promising possibilities of using an agarose spot migration assay to examine the ability of extracellular vesicles to attract other cells in a controlled environment. The study has been recently published in the journal BMC Biology.
The research, led by Cima Universidad de Navarra, sheds light on new possibilities for addressing various types of cancer. This work has been carried out in collaboration with Dr Carolina Armengol, leader of IGTP’s Childhood Liver Oncology (C-LOG) group, a pioneer in the study of childhood liver cancer in Spain.
The first urine test that detects kidney fibrosis as an alternative to kidney biopsies, an initiative from the IVECAT group, and a project applying artificial intelligence to rapidly categorise stroke patients and enhance their recovery chances, from the Neurovascular Research group, are two of the fifteen projects from Catalan research centres selected within the 2023 call of the new CaixaImpulse Healthcare Innovation programme.